PUBLIC COMPANY
saveTianjin Medical University Cancer Institute and Hospital
updated 2mo ago
community read0 votes
🐶 often sniffed alongside
top 8- tagOncology6 co-mentions · 2 sources
- drugpaclitaxel1 co-mentions · 1 sources
- drugSOR-0071 co-mentions · 1 sources
- druggemcitabine1 co-mentions · 1 sources
- drugFLUOROURACIL1 co-mentions · 1 sources
- drugpaclitaxel albumin bound1 co-mentions · 1 sources
- drugEfudex1 co-mentions · 1 sources
- drugAG [gemcitabine + nab-paclitaxel]1 co-mentions · 1 sources
pipeline
1
marketed
0
phase 3
0
catalysts ytd
2
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Unknown
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase2A Phase II Clinical Study of Utidelone and Bevacizumab With or Without Etoposide in Patients With Brain Metastases From Malignant Solid Tumors
- phase1A Clinical Study to Evaluate GK01 Cell Injection in Combination With PD-1 Monoclonal Antibody for Advanced Solid Tumors
- phase1A Single-arm, Open-label Study of GK01 in Combination With or Without Chemotherapy for the Adjuvant Treatment of Solid Tumors
- phase3Observation of the Effect of Preoperative Use of Dexmedetomidine Hydrochloride Nasal Spray on Optimizing Awake Sedation During Breast-Conserving Surgery for Breast Cancer and Postoperative Awake Status
- phase1RN1201 Injection in Newly Diagnosed High-Risk Cytogenetic Multiple Myeloma
- phase1A Study of C-CAR039 Treatment in Subjects With r/r NHL SubjectsNon-Hodgkin's Lymphoma
- phase1A Clinical Study of CHT102 in MSLN-Positive Advanced Pancreatic Cancer
- phase1A Clinical Study of CHT101 in CD70-Positive Relapsed or Refractory Hematological Malignancies
🐶 Hiring Signal
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that